Lexeo Therapeutics Inc Sustainability Reports
Lexeo Therapeutics, Inc. is a clinical-stage genetic medicines company focused on reshaping heart health and treating Alzheimer's disease. The company develops AAV-based gene therapies targeting the underlying genetic causes of cardiovascular diseases and APOE4-associated Alzheimer's disease.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00YB1C8N4
1 reports from 2023 to 2023
